Annual Cash & Cash Equivalents
$5.26B$298.00M-5.36%
Summary
- Current Value
- As of today, ABBV annual cash & cash equivalents is $5.26B, down -5.36% on
- Historical Performance
- ABBV annual cash & cash equivalents is down -43.04% over the past 3 years, down -38.00% over the past 5 years
- All-Time High Comparison
- ABBV annual cash & cash equivalents is currently -86.83% below its historical high of $39.92B set on
- 3-Year Low Comparison
- ABBV annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- ABBV annual cash & cash equivalents is higher than 97.90% of companies in Healthcare sector
Cash and Cash Equivalents Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $5.26B | -5.4% | -43.0% | -38.0% | +179.1% | |
| Quarterly Cash & Cash Equivalents | $6.57B | +1.6% | -25.1% | -23.6% | – | |
| Price | $246.20 | +24.0% | +66.7% | +113.9% | – | |
| Annual Current Assets | $29.06B | +13.6% | +2.1% | +20.2% | +253.6% | |
| Annual Total Liabilities | $137.19B | +4.1% | +12.9% | -0.2% | +2425.7% | |
| Annual Working Capital | -$14.23B | -8.1% | -1223.4% | -217.0% | -419.2% | |
| Annual Net Income | $4.19B | -1.3% | -64.4% | -8.1% | +0.4% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $12.82B | -59.0% | |
| 5Y | $12.82B | -59.0% | |
| All | $39.92B | -86.8% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $5.26B | at low | |
| 5Y | $5.26B | at low | |
| All | $653.58M | +704.3% |
Cash and Cash Equivalents History
FAQ
- What is the current annual cash & cash equivalents of ABBV?
- As of today, ABBV annual cash & cash equivalents is $5.26B
- What is 1-year change in ABBV annual cash & cash equivalents?
- ABBV annual cash & cash equivalents is down -5.36% year-over-year
- What is 3-year change in ABBV annual cash & cash equivalents?
- ABBV annual cash & cash equivalents is down -43.04% over the past 3 years
- How far is ABBV annual cash & cash equivalents from its all-time high?
- ABBV annual cash & cash equivalents is currently -86.83% below its historical high of $39.92B set on December 31, 2019
- How does ABBV annual cash & cash equivalents rank versus sector peers?
- ABBV annual cash & cash equivalents is higher than 97.90% of companies in Healthcare sector
- When is ABBV next annual earnings release?
- As of today, the next annual earnings release for ABBV has not been scheduled
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Quarterly Cash & Cash Equivalents
$6.57B$2.82B-30.05%
Summary
- Current Value
- As of today, ABBV quarterly cash & cash equivalents is $6.57B, down -30.05% on
- Historical Performance
- ABBV quarterly cash & cash equivalents is up +1.58% year-over-year, down -25.06% over the past 3 years
- All-Time High Comparison
- ABBV quarterly cash & cash equivalents is currently -84.03% below its historical high of $41.14B set on
- 3-Year Low Comparison
- ABBV quarterly cash & cash equivalents is +26.91% above its 3-year low of $5.18B reached on
- Sector Comparison
- ABBV quarterly cash & cash equivalents is higher than 98.68% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $6.57B | -30.1% | +1.6% | -25.1% | -23.6% | |
| Annual Cash & Cash Equivalents | $5.26B | – | -5.4% | -43.0% | -38.0% | |
| Price | $246.20 | +19.4% | +24.0% | +66.7% | +113.9% | |
| Quarterly Current Assets | $33.67B | +0.4% | +15.1% | +16.7% | +29.5% | |
| Quarterly Total Liabilities | $141.00B | -1.4% | +2.7% | +15.1% | +4.2% | |
| Quarterly Working Capital | -$7.97B | +7.0% | +24.1% | -135.4% | -196.9% | |
| Quarterly Net Income | $3.62B | +427.2% | +289.0% | +79.7% | +381.6% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $9.39B | -30.1% | |
| 3Y | $18.07B | -63.6% | |
| 5Y | $18.07B | -63.6% | |
| All | $41.14B | -84.0% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $5.26B | +25.0% | |
| 3Y | $5.18B | +26.9% | |
| 5Y | $5.18B | +26.9% | |
| All | $42.99M | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
- What is the current quarterly cash & cash equivalents of ABBV?
- As of today, ABBV quarterly cash & cash equivalents is $6.57B
- What is ABBV quarterly cash & cash equivalents most recent change?
- ABBV quarterly cash & cash equivalents was down -30.05% on June 30, 2026
- What is 1-year change in ABBV quarterly cash & cash equivalents?
- ABBV quarterly cash & cash equivalents is up +1.58% year-over-year
- How far is ABBV quarterly cash & cash equivalents from its all-time high?
- ABBV quarterly cash & cash equivalents is currently -84.03% below its historical high of $41.14B set on March 31, 2020
- How does ABBV quarterly cash & cash equivalents rank versus sector peers?
- ABBV quarterly cash & cash equivalents is higher than 98.68% of companies in Healthcare sector
- When is ABBV next earnings release?
- The next earnings release for ABBV is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- ABBV Official Website www.abbvie.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm
- ABBV Profile on Yahoo Finance finance.yahoo.com/quote/ABBV
- ABBV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abbv